XML 82 R69.htm IDEA: XBRL DOCUMENT v3.20.2
STOCK-BASED COMPENSATION - Narrative (Details)
3 Months Ended 6 Months Ended
Jun. 30, 2020
USD ($)
employees
shares
Jun. 30, 2019
USD ($)
Jun. 30, 2020
USD ($)
employees
shares
Jun. 30, 2019
USD ($)
Stock-based compensation        
Stock-based compensation expense $ 40,000,000.0 $ 20,100,000 $ 69,600,000 $ 36,300,000
Incremental share based compensation expense $ 0   $ 0  
Number of employees impacted by change in operational milestones | employees 36   36  
Non-cash stock-based compensation expense $ 1,800,000      
Stock Plans        
Stock-based compensation        
Unrecognized compensation cost 300,900,000   $ 300,900,000  
Weighted average period for recognition of cost     3 years  
Merger Agreement with Genomic Health, Inc.        
Stock-based compensation        
Non-cash stock-based compensation expense $ 600,000   $ 3,500,000  
Option Plan Shares        
Stock-based compensation        
Accelerated vesting, shares | shares 708      
Option Plan Shares | Merger Agreement with Genomic Health, Inc.        
Stock-based compensation        
Accelerated vesting, shares | shares 9,132   43,480  
Restricted Shares and RSUs        
Stock-based compensation        
Accelerated vesting, shares | shares 33,123      
Restricted Shares and RSUs | Merger Agreement with Genomic Health, Inc.        
Stock-based compensation        
Accelerated vesting, shares | shares 10,525   28,814